ANGELA MERKEL has performed an embarrassing U-turn on the utilization of the AstraZeneca jab as Germany's vaccine authority confirmed it'll now be recommended to people over the age of 65.

Germany's vaccine authority will recommend AstraZeneca's coronavirus vaccine for over-65s during a move that promises an easing of the availability constraints that have slowed the country's vaccine roll-out. 

German Health Minister Jens Spahn confirmed the news adding that a replacement study shows that if the interval between the primary and therefore the second AstraZeneca shots is 12 weeks, the vaccine is even simpler.

The German Chancellor had previously banned the utilization of the Oxford vaccine for over-65s and provided second shots would tend to people within four weeks, moving faraway from the UK's 12-weeks approach. 

"This is sweet news for older people that are expecting a vaccine. They will now be vaccinated more quickly," the ministry said.

"We will shortly issue a regulation implementing both recommendations."

Germany’s vaccine programme, like those of other EU member states, has been lagging dramatically behind the UK’s.

Only around 6 percent of the German population has received its first jab versus 30 percent for Britain.

The UK has given a primary vaccine to quite 20 million people whereas Germany is languishing below five million.


However, Germany has given two shots of the vaccines to a better proportion of its population, at 2.7 percent versus 1.3 percent for Britain.

Mr Spahn said approving the AstraZeneca jab for the over-65s would dramatically speed up Germany’s vaccination programme.

Speaking to the BBC Carsten Watzl, head of the German Society for Immunology, urged Ms Merkel to require the Oxford vaccine survive TV to demonstrate it's safe after she said she wouldn't qualify for the jab under German rules. 

French President Emmanuel Macron caused outrage earlier this year by falsely claiming the vaccine is “quasi-ineffective” for those aged 65 and over.

France has since u-turned and approved the jab for all age groups.

The AstraZeneca vaccine also will finally be administered to people over 55 in Belgium, allowing the authorities to "immediately start" the anti-Covid vaccination of the elderly population, Minister of Health Frank Vandenbroucke announced on Wednesday evening.

A month ago, Belgium decided to initially reserve the AstraZeneca vaccine for 18-55 year olds because there was no sufficient data on its effectiveness beyond this age.

But recent studies within the UK and Israel have shown that it "also offers people over the age of 55 good protection against illness and hospitalisation linked to COVID-19," said a press release released after a gathering of all the ministers - at the federal level and therefore the regions - liable for Health in Belgium.

The ministers decided to follow the positive opinion given on Tuesday by the Superior Health Council.

As a results of this expansion, "the vaccination of individuals over 65 (about 2.2 million people) can begin immediately," the statement added.

"This should make it possible to hurry up the protection of the foremost vulnerable."

To date, Belgium, a rustic of 11.5 million inhabitants, has vaccinated 5.70 percent of its population over 18 with a primary dose (about 525,000 people), and 3.47 percent with the 2 injections required (320,000).

Since January, priority has been given to residents and employees of retirement homes, then to hospital staff, and from February the so-called "front-line" caregivers, dentists and medical professionals.

The vaccination campaign has been criticised for its slowness and Frank Vandenbroucke himself admitted Sunday there are "hiccups" and "unacceptable delays."

Vaccination in centres for people over 65, the step planned from next week, risked a difficult start by relying only on the Pfizer/BioNTech and Moderna vaccines.

 Belgium has reserved a complete of 7.7 million doses of AstraZeneca vaccine, the most important of its anti-Covid vaccine orders.